Published in Semin Vasc Surg on September 01, 2010
Recurrent venous thromboembolism: what is the risk and how to prevent it. Scientifica (Cairo) (2012) 0.82
Cardiac arrest caused by multiple recurrent pulmonary embolism. Case Rep Med (2011) 0.75
Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis. BMJ Open (2014) 0.75
Thrombophilia with an onset symptom of intracranial venous thrombosis: A case report and review of the literature. Exp Ther Med (2017) 0.75
Multidetector computed tomography for acute pulmonary embolism. N Engl J Med (2006) 7.57
Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A (2010) 5.69
Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg (2004) 3.41
Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood (2004) 3.31
von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood (2010) 2.82
The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg (2011) 2.15
Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators. Am J Med (2006) 2.13
Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators. Radiology (2007) 2.09
Osteomyelitis of the foot and toe in adults is a surgical disease: conservative management worsens lower extremity salvage. Ann Surg (2005) 1.76
P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vasc Surg (2003) 1.64
A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg (2010) 1.59
Identifying patients at high risk for venous thromboembolism requiring treatment after outpatient surgery. Ann Surg (2012) 1.55
Proteomics of microparticles after deep venous thrombosis. Thromb Res (2010) 1.50
Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model. Arterioscler Thromb Vasc Biol (2004) 1.49
Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg (2007) 1.47
Pediatric renovascular hypertension: 132 primary and 30 secondary operations in 97 children. J Vasc Surg (2006) 1.47
Critical review of mouse models of venous thrombosis. Arterioscler Thromb Vasc Biol (2012) 1.46
L-selectin-mediated neutrophil recruitment in experimental rodent aneurysm formation. Circulation (2005) 1.44
Impaired vasoreactivity despite an increase in plasma nitrite in patients with abdominal aortic aneurysms. J Vasc Surg (2002) 1.39
Tissue loss, early primary graft occlusion, female gender, and a prohibitive failure rate of secondary infrainguinal arterial reconstruction. J Vasc Surg (2002) 1.39
Variation in death rate after abdominal aortic aneurysmectomy in the United States: impact of hospital volume, gender, and age. Ann Surg (2002) 1.37
Decreased venous thrombosis with an oral inhibitor of P selectin. J Vasc Surg (2005) 1.34
Targeted deletion of CCR2 impairs deep vein thombosis resolution in a mouse model. J Immunol (2006) 1.30
Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. J Vasc Surg (2005) 1.30
Sonographic elasticity imaging of acute and chronic deep venous thrombosis in humans. J Ultrasound Med (2006) 1.29
A negative carotid plaque area test is superior to other noninvasive atherosclerosis studies for reducing the likelihood of having underlying significant coronary artery disease. Arterioscler Thromb Vasc Biol (2005) 1.29
Thrombogenesis with continuous blood flow in the inferior vena cava. A novel mouse model. Thromb Haemost (2010) 1.23
Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation. Thromb Haemost (2008) 1.22
Interleukin-6: a potential target for post-thrombotic syndrome. Ann Vasc Surg (2010) 1.18
D-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study. Thromb Haemost (2005) 1.17
Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution. Arterioscler Thromb Vasc Biol (2010) 1.16
Statins, inflammation and deep vein thrombosis: a systematic review. J Thromb Thrombolysis (2012) 1.13
Neutropenia impairs venous thrombosis resolution in the rat. J Vasc Surg (2003) 1.12
Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis. Clin Appl Thromb Hemost (2011) 1.09
Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg (2012) 1.07
Venous thromboembolism in cancer patients undergoing major surgery. Ann Surg Oncol (2008) 1.07
Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularization. Thromb Haemost (2006) 1.07
Acute venous disease: venous thrombosis and venous trauma. J Vasc Surg (2007) 1.06
Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis. J Vasc Surg (2006) 1.05
CT venography and compression sonography are diagnostically equivalent: data from PIOPED II. AJR Am J Roentgenol (2007) 1.05
Staging deep venous thrombosis using ultrasound elasticity imaging: animal model. Ultrasound Med Biol (2004) 1.04
Resolution of venous thrombosis using a novel oral small-molecule inhibitor of P-selectin (PSI-697) without anticoagulation. Thromb Haemost (2007) 1.04
Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis. Thromb Haemost (2007) 1.03
Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis. Thromb Haemost (2009) 1.02
Methods of Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III). Semin Nucl Med (2008) 1.00
Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism. Thromb Haemost (2010) 0.99
Clinical application of sonographic elasticity imaging for aging of deep venous thrombosis: preliminary findings. J Ultrasound Med (2003) 0.98
Metabolic consequences of acute limb ischemia and their clinical implications. Semin Vasc Surg (2009) 0.98
Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery ® and the American Venous Forum. J Vasc Surg (2014) 0.98
Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis. J Vasc Surg (2011) 0.97
Aging is associated with impaired thrombus resolution in a mouse model of stasis induced thrombosis. Thromb Res (2009) 0.96
Southern Association for Vascular Surgery William J. von Leibig Award. Inflammation and intimal hyperplasia associated with experimental pulmonary embolism. J Vasc Surg (2002) 0.96
Correspondence of ultrasound elasticity imaging to direct mechanical measurement in aging DVT in rats. Ultrasound Med Biol (2005) 0.95
Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution. J Surg Res (2007) 0.95
P-selectin/ PSGL-1 inhibitors versus enoxaparin in the resolution of venous thrombosis: a meta-analysis. Thromb Res (2009) 0.94
Postthrombotic vein wall remodeling: preliminary observations. J Vasc Surg (2010) 0.94
Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin. J Vasc Surg (2008) 0.93
P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model. J Vasc Surg (2002) 0.93
The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling. J Vasc Surg (2013) 0.92
Electrolytic inferior vena cava model (EIM) of venous thrombosis. J Vis Exp (2011) 0.91
Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline. Ann Vasc Surg (2010) 0.91
Factors associated with outcome after interventional treatment of symptomatic iliac vein compression syndrome. J Vasc Surg (2007) 0.90
Iliorenal bypass: indications and outcomes following 41 reconstructions. Ann Vasc Surg (2007) 0.89
Regarding "Impact of screening versus symptomatic measurement of deep vein thrombosis in a national quality improvement registry". J Vasc Surg (2013) 0.87
Increasing awareness about venous disease: The American Venous Forum expands the National Venous Screening Program. J Vasc Surg (2008) 0.87
Risk factors associated with venous thromboembolic events in patients with malignancy. Blood Coagul Fibrinolysis (2006) 0.87
Venous thromboembolism: regional differences in the nationwide inpatient sample, 1993 to 2000. Vascular (2005) 0.86
Deep vein thrombosis resolution is not accelerated with increased neovascularization. J Vasc Surg (2004) 0.86
Do galectins play a role in venous thrombosis? a review. Thromb Res (2009) 0.86
Microparticle surface protein are associated with experimental venous thrombosis: a preliminary study. Clin Appl Thromb Hemost (2009) 0.86
Increased PAI-1 in females compared with males is protective for abdominal aortic aneurysm formation in a rodent model. Am J Physiol Heart Circ Physiol (2012) 0.85
P-selectin inhibition decreases post-thrombotic vein wall fibrosis in a rat model. Surgery (2003) 0.85
CT venography for deep venous thrombosis: continuous images versus reformatted discontinuous images using PIOPED II data. AJR Am J Roentgenol (2007) 0.85
Endovenous laser ablation: venous outcomes and thrombotic complications are independent of the presence of deep venous insufficiency. J Vasc Surg (2008) 0.84
Biomarkers for the diagnosis of deep vein thrombosis. Expert Opin Med Diagn (2012) 0.84
The electrolytic inferior vena cava model (EIM) to study thrombogenesis and thrombus resolution with continuous blood flow in the mouse. Thromb Haemost (2013) 0.83
Novel Biomarkers Associated with Deep Venous Thrombosis: A Comprehensive Review. Biomark Insights (2008) 0.83
Mouse complete stasis model of inferior vena cava thrombosis. J Vis Exp (2011) 0.83
Inflammation-dependent thrombosis. Front Biosci (2005) 0.82
Compression stockings and venous function. Arch Surg (2002) 0.82
Experimental pulmonary embolism: effects of the thrombus and attenuation of pulmonary artery injury by low-molecular-weight heparin. J Vasc Surg (2006) 0.82
A role for interleukin-10 in the assessment of venous thromboembolism risk in injured patients. J Trauma (2006) 0.82
Outcome of surgical and endoluminal intervention for infrainguinal bypass anastomotic strictures. Vasc Endovascular Surg (2006) 0.81
Matrix metalloproteinase-9 deletion is associated with decreased mid-term vein wall fibrosis in experimental stasis DVT. Thromb Res (2013) 0.80
Soluble P-selectin for the diagnosis of lower extremity deep venous thrombosis. J Vasc Surg Venous Lymphat Disord (2013) 0.80
Mapping the future: organizational, clinical, and research priorities in venous disease. J Vasc Surg (2007) 0.80
Endovascular treatment of abdominal aortic aneurysm is associated with a low incidence of deep venous thrombosis. J Vasc Surg (2002) 0.79
Acute limb ischemia associated with type B aortic dissection: clinical relevance and therapy. Surgery (2006) 0.79
Cellular IL-10 is more effective than viral IL-10 in decreasing venous thrombosis. J Surg Res (2003) 0.78
Preface: acute and chronic venous disease. Current status and future directions. J Vasc Surg (2007) 0.78
Venous thromboembolism and cancer. Curr Probl Surg (2007) 0.77
The treatment of deep venous thrombosis, including the newer agents. Dis Mon (2005) 0.77
The effect of abdominal wall plication on intra-abdominal pressure and lower extremity venous flow: a case report. J Plast Reconstr Aesthet Surg (2011) 0.77
Results of the national pilot screening program for venous disease by the American Venous Forum. J Vasc Surg (2007) 0.77
Inflammation and thrombosis: new insights. Front Biosci (Schol Ed) (2012) 0.77
Myeloid cell tissue factor does not contribute to venous thrombogenesis in an electrolytic injury model. Thromb Res (2011) 0.77
Venous thromboembolic events in the rehabilitation setting. PM R (2010) 0.76
Factor VIII and race: a new dimension in hypercoagulability. Thromb Haemost (2003) 0.75
Invited commentary. J Vasc Surg (2010) 0.75
Cost of routine screening for carotid and lower extremity occlusive disease in patients with abdominal aortic aneurysms. J Vasc Surg (2002) 0.75